Randomized intervention studies in human polycystic kidney and liver disease.
Schrier
Robert W
RW
D018450:Disease Progression; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D008107:Liver Diseases / Q000188:drug therapy*; D015282:Octreotide / Q000494:pharmacology / Q000627:therapeutic use*; D016891:Polycystic Kidney, Autosomal Dominant / Q000188:drug therapy*; D020123:Sirolimus / Q000494:pharmacology / Q000627:therapeutic use*; D013004:Somatostatin / Q000031:analogs & derivatives; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D013004:Somatostatin; D015282:Octreotide; D020123:Sirolimus